Immunotherapy Might Improve Survival Outcomes in Late-Stage … – WMFE
WMFE |
Immunotherapy Might Improve Survival Outcomes in Late-Stage …
WMFE A study in the New England Journal of Medicine found that immunotherapy could improve survival outcomes in patients with an aggressive form of lung cancer. Florida Hospital Cancer Institute’s Dr. Mark Socinski says the drug should be a first-line … Opinion | The Problem With Miracle Cancer Cures – The New York …New York Times Immunotherapy improves statistics of survival in lung cancer patientsPulse Headlines Hellman Expands on TMB Testing in Lung Cancer – OncLiveOncLive WSYM-TV all 7 news articles » |
Proactive Investors Australia |
Regeneus director supports stem cell technology through on-market purchase
Proactive Investors Australia Regeneus Ltd’s (ASX:RGS) recently appointed Japanese-based non-executive director, Leo Lee, has demonstrated his confidence in the company’s stem cell technology platform through an on-market purchase of shares. Lee purchased 1,011,000 shares for a … |
Actualité Houssenia Writing |
CRISPR : Modification de l’ADN en dehors d’une cellule
Actualité Houssenia Writing Dans l’étude actuelle, Kmiec et ses collègues décrivent le développement d’un outil CRISPR sans cellule qui peut modifier les gènes contenus dans un plasmide d’ADN. Un plasmide est un type de molécule d’ADN qui peut être retiré d’une cellule et … |